Delivery Order SPE2DB20D2001-SPE2DB25FPNAQ
Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 25 mg tablets (90-count) valued at $5,569.27 under a firm fixed price contract. This award, issued on July 31, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ (mirabegron) is a beta-3 agonist medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count quantity) valued at $7,075.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set to be completed by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ...
- The Defense Logistics Agency awarded a delivery order valued at $6,227.41 to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for MYRBETRIQ ER 50 MG tablets (quantity: 90-count supply) with a ceiling value of $3,120.05 under a firm fixed price contract. This is a non-set-aside award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion potential value through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (90 count) on September 10, 2025, with a ceiling value of $7,323.42 and firm fixed pricing. This non-set-aside, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (90-count supply) on September 9, 2025, with a ceiling value of $3,650.59. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a non-competitive set-aside contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $20,957.72 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 50 mg tablets (90-count units). This competitive award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,663.48 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 50 mg tablets (90-count units). The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, operates under firm fixed-price terms with no set-aside designation, indicating competitive award. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $13,844.76. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The order is scheduled for completion by September 19, 2025, and will be performed at the contractor's Conshohocken,...
- This delivery order, valued at $1,219.26, was awarded on August 29, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 25 mg tablets (90-count). The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be completed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...